MarketPulse
L

$LEGN

1 article found
1 positive
0 negative
0 neutral
The Motley FoolThe Motley Fool··Eric Volkman

Legend Biotech Surges 18% on Bullish Analyst Calls and Sector M&A Momentum

Legend Biotech surges 18% on bullish analyst upgrades and momentum from Eli Lilly's $7B CAR-T acquisition, with CD19/CD20 therapy driving investor enthusiasm.
LLYLEGNacquisitionanalyst upgrade